Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Sheer and colleagues reviewed electronic health record data from 26,408 adults treated in the OneFlorida+ network from 2014 to 2024, covering 14 healthcare organizations across Florida, Georgia, and Alabama
**p = 0.0038 (clear cell renal cell carcinoma)
The clinical use of iron chelators in treating iron load disorders makes it a potential therapeutical strategy in the prevention of ferroptosis-related CVDs
Your protocol is supervised throughout
Patients without Neurofibromatosis type 1 (NF1) tend to have better outcomes than those with NF1-associated MPNST, as NF1-related tumors are more likely to be multifocal, high-grade, and resistant to therapy (Evans et al., 2021)
US$ 23.12
US$ 22.26
US$ 23.23
US$ 29.28
US$ 26.28
US$ 26.40
